145.07
0.94%
+1.35
After Hours:
145.07
Overview
News
Price History
Option Chain
Why BCPC Down?
Discussions
Forecast
Stock Split
Dividend History
Balchem Corp. stock is currently priced at $145.07, with a 24-hour trading volume of 69,644.
It has seen a +0.94% increased in the last 24 hours and a -6.74% declined in the past month.
The chart indicates a potential bullish trend, as the stock is above the $143.9 pivot point. If it approaches the $146.0 resistance level, significant changes may occur.
Balchem Corp. Stock (BCPC) Financials Data
Balchem Corp. (BCPC) Revenue 2024
BCPC reported a revenue (TTM) of $922.44 million for the quarter ending December 31, 2023, a -2.11% decline year-over-year.
Balchem Corp. (BCPC) Net Income 2024
BCPC net income (TTM) was $108.54 million for the quarter ending December 31, 2023, a +3.01% increase year-over-year.
Balchem Corp. (BCPC) Cash Flow 2024
BCPC recorded a free cash flow (TTM) of $145.87 million for the quarter ending December 31, 2023, a +64.65% increase year-over-year.
Balchem Corp. (BCPC) Earnings per Share 2024
BCPC earnings per share (TTM) was $3.35 for the quarter ending December 31, 2023, a +3.08% growth year-over-year.
Balchem Corp. Stock (BCPC) Insider Trading
Insider Trading | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total |
---|---|---|---|---|---|---|---|
Tignor Michael Brent | SVP & Chief HR Officer |
Mar 08 '24 |
Option Exercise |
85.40 |
4,200 |
358,680 |
13,707 |
Tignor Michael Brent | SVP & Chief HR Officer |
Mar 08 '24 |
Sale |
157.52 |
5,339 |
840,985 |
8,368 |
Wineinger Matthew David | Director |
Mar 04 '24 |
Sale |
156.89 |
1,333 |
209,128 |
6,162 |
Backus William A. | VP & Chief Accounting Officer |
Feb 26 '24 |
Sale |
155.19 |
7,000 |
1,086,304 |
5,914 |
Backus William A. | VP & Chief Accounting Officer |
Feb 23 '24 |
Option Exercise |
80.44 |
9,180 |
738,421 |
22,094 |
Backus William A. | VP & Chief Accounting Officer |
Feb 23 '24 |
Sale |
156.37 |
9,180 |
1,435,469 |
12,914 |
Harris Theodore L | Chairman, President & CEO |
Feb 22 '24 |
Option Exercise |
59.11 |
34,350 |
2,030,398 |
100,762 |
Harris Theodore L | Chairman, President & CEO |
Feb 22 '24 |
Sale |
154.29 |
34,350 |
5,300,026 |
66,412 |
Backus William A. | VP & Chief Accounting Officer |
Feb 21 '24 |
Option Exercise |
60.85 |
15,000 |
912,750 |
27,914 |
Sestrick Michael Robert | SVP & Chief Technology Officer |
Feb 21 '24 |
Option Exercise |
78.56 |
11,100 |
871,999 |
17,836 |
Balchem Corp. Stock (BCPC) Latest News
Balchem Corporation Announces Quarterly Conference Call for First Quarter Financial Results on May 3, 2024
GlobeNewswire Inc.
Blachem (BCPC) Is a Great Choice for 'Trend' Investors, Here's Why
Zacks Investment Research
Is Balchem (BCPC) Stock Outpacing Its Basic Materials Peers This Year?
Zacks Investment Research
Time to Buy These Top-Rated Basic Materials Stocks Amid an Uptick in Inflationary Data
Zacks Investment Research
The Zacks Analyst Blog Highlights Atmos Energy, Balchem, Cardinal Health, Casey's and Colgate-Palmolive
Zacks Investment Research
5 Low-Beta Stocks for Safe Returns as Inflation Rises Again
Zacks Investment Research
About Balchem Corp.
Balchem Corporation develops, manufactures, and markets specialty performance ingredients and products for the food, nutritional, feed, pharmaceutical, medical sterilization, and industrial markets in the United States and internationally. The company's Human Nutrition & Health segment supplies ingredients in the food and beverage industry. Its products include creamer and chocolate systems, dairy replacers, powdered fats, nutritional beverage bases, beverages, juice and dairy bases, ice cream bases and variegates, cereals, grain based snacks, and cereal based ingredients. This segment also offers microencapsulation solutions; and human grade choline nutrients and mineral amino acid chelated products for wellness applications. Its Animal Nutrition & Health segment provides microencapsulated products to enhance health and milk production in ruminant animals; chelation technology, which offers enhanced nutrient absorption for various species of production and companion animals; and choline chloride, a nutrient for monogastric animal health. The company's Specialty Products segment offers ethylene oxide primarily for use in the health care industry; and single use canisters with ethylene oxide for sterilizing re-usable devices. It also sells propylene oxide, a fumigant to aid in the control of insects and microbiological spoilage, as well as to reduce bacterial and mold contamination in shell and processed nut meats, processed spices, cacao beans, cocoa powder, raisins, figs, and prunes; and chelated minerals for high value crops. The company's Industrial Products segment provides choline chloride derivatives for hydraulic fracturing of shale natural gas wells; and methylamines, which are building blocks for the manufacture of choline products, as well as used in industrial applications. The company sells its products through sales force, independent distributors, and sales agents. Balchem Corporation was founded in 1967 and is headquartered in New Hampton, New York.
Cap:
|
Volume (24h):